Your browser doesn't support javascript.
loading
Inhibitor development in patients with type 3 Von Willebrand disease, a comprehensive study on 99 Iranian patients.
Jazebi, Mohammad; Baghaipour, Mohammad Reza; Bahoush, Gholam Reza; Ala, Fereydoun; Dorgalaleh, Akbar; Moazezi Nekoei Asl, Seyedeh Somayeh; Bahraini, Mehran; Baghaipour, Nazanin; Tabibian, Shadi.
Afiliação
  • Jazebi M; Iranian Comprehensive Hemophilia Care Center, Tehran, Iran.
  • Baghaipour MR; Iranian Comprehensive Hemophilia Care Center, Tehran, Iran.
  • Bahoush GR; Iranian Comprehensive Hemophilia Care Center, Tehran, Iran.
  • Ala F; Department of Pediatrics, Aliasghar Children's Hospital, School of Medicine, Iran University of Medical Science, Tehran, Iran.
  • Dorgalaleh A; Iranian Comprehensive Hemophilia Care Center, Tehran, Iran.
  • Moazezi Nekoei Asl SS; Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Bahraini M; Iranian Comprehensive Hemophilia Care Center, Tehran, Iran.
  • Baghaipour N; Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Tabibian S; Iranian Comprehensive Hemophilia Care Center, Tehran, Iran.
Haemophilia ; 27(4): 520-e524, 2021 Jul.
Article em En | MEDLINE | ID: mdl-33550685
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças de von Willebrand / Doença de von Willebrand Tipo 2 / Doença de von Willebrand Tipo 3 Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças de von Willebrand / Doença de von Willebrand Tipo 2 / Doença de von Willebrand Tipo 3 Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article